Basic Information
| LncRNA/CircRNA Name | ANRIL |
| Synonyms | CDKN2B-AS1, ANRIL, CDKN2B-AS, CDKN2BAS, NCRNA00089, PCAT12, p15AS |
| Region | GRCh38_9:21994778-22121097 |
| Ensemble | ENSG00000240498 |
| Refseq | NR_003529 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioblastoma |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | cell lines (U118, MG-U87, MG-LN18) |
| Expression Pattern | down-regulated |
| Function Description | The lncRNAs (INK4 Locus) ANRIL, H19, PCAT-1 indicated low expression. Moreover, ANRIL expression was similar to H19 in the glioblastoma cell lines. These lncRNAs showed a significant decrease 5.3, 5.3, 2.3 fold in GBM cell lines, respectively (Fig. 1b). These findings showed that PCAT-1, ANRIL, H19 could inhibit GBM cell proliferation, invasion and migration. |
| Pubmed ID | 27306825 |
| Year | 2016 |
| Title | Analysis of dysregulated long non-coding RNA expressions in glioblastoma cells. |
External Links
| Links for ANRIL | GenBank HGNC NONCODE |
| Links for glioblastoma | OMIM COSMIC |